The effect of pre-analytical variability on the measurement of MRM-MS-based mid- to high-abundance plasma protein biomarkers and a panel of cytokines
about
Evaluating the effects of preanalytical variables on the stability of the human plasma proteomeSYSTEMIC PHARMACOKINETICS AND PHARMACODYNAMICS OF INTRAVITREAL AFLIBERCEPT, BEVACIZUMAB, AND RANIBIZUMAB.Comprehensive analysis of protein digestion using six trypsins reveals the origin of trypsin as a significant source of variability in proteomics.Systemic pharmacokinetics following intravitreal injections of ranibizumab, bevacizumab or aflibercept in patients with neovascular AMDEffect of Nigella sativa on immune response in treadmill exercised ratPhenotype-Driven Plasma Biobanking Strategies and MethodsPre-Analytical Parameters Affecting Vascular Endothelial Growth Factor Measurement in Plasma: Identifying Confounders.Plasma degradome affected by variable storage of human blood.Comparison of serum, EDTA plasma and P100 plasma for luminex-based biomarker multiplex assays in patients with chronic obstructive pulmonary disease in the SPIROMICS study.Clinical proteomic biomarkers: relevant issues on study design & technical considerations in biomarker development.Biopsies: next-generation biospecimens for tailoring therapy.Targeted quantitation of CVD-linked plasma proteins for biomarker verification and validation.Pre-analytical and analytical variability in absolute quantitative MRM-based plasma proteomic studies.Mass spectrometry based biomarker discovery, verification, and validation--quality assurance and control of protein biomarker assays.Important options available--from start to finish--for translating proteomics results to clinical chemistry.Biofluid infrared spectro-diagnostics: pre-analytical considerations for clinical applications.Exploring phlebotomy technique as a pre-analytical factor in proteomic analyses by mass spectrometry.Influence of subretinal fluid in advanced stage retinopathy of prematurity on proangiogenic response and cell proliferation.Assessment of the influence of the patient's inflammatory state on the accuracy of a haptoglobin selected reaction monitoring assay.Cytokine signatures in chronic fatigue syndrome patients: a Case Control Study and the effect of anakinra treatment.Understanding preanalytical variables and their effects on clinical biomarkers of oncology and immunotherapy.Effects of Intravitreal Aflibercept on Galectin-1 and Vascular Endothelial Growth Factor-A Plasma Levels in Patients with Diabetic Retinopathy.Impact of Prolonged Blood Incubation and Extended Serum Storage at Room Temperature on the Human Serum Metabolome.Multiplexed MRM-based quantitation of candidate cancer biomarker proteins in undepleted and non-enriched human plasma.
P2860
Q30372676-8CFAC144-2DDD-4FBB-8FE7-BB80E901AEA2Q30490738-ABBF41B1-574A-4BC0-B250-82E2371D8E5AQ33827075-52D21DB5-931C-47E1-B834-6B607F56813DQ34608306-4D7EF134-46CE-4105-9F3F-FF615CCB86A9Q35404245-66B43D49-C841-440A-8AF4-E3EBE10F5920Q35674060-7F78BF6B-AECF-4B20-915C-9614C4BA1232Q35884984-5186C7BD-3E8F-4E6C-A1FB-EC12D8FD18E5Q37286747-E8EDB494-12DD-46C2-9B79-075B08BA7FCEQ37592722-65CAB770-5F2D-4134-991D-8A301376609FQ37714579-0A26AC04-F8DD-4325-BA4D-2D26C9675745Q38116896-52A7CE38-FE2F-4549-9DD9-089515ACC894Q38160931-15FB59BF-8454-4B5E-BA35-7C9E6710A2BEQ38164428-80CD9CF3-5F94-417C-A1A3-DE57B5F3100DQ38203040-235408E3-FE25-439C-AEB6-C33262DA3238Q38282797-6D44AC51-1208-49CF-85C5-E2733D6974CBQ39860343-2715E135-2767-4FF5-B3F4-3E6F52D7949CQ40411051-5557D759-20A0-4947-B888-6965CB334732Q41021546-41E44338-8485-45DC-AAC7-25FC5A4638F0Q42085201-33871D46-B2D5-41F1-9EB3-3DA462EA9DF8Q47144415-931575F6-E55A-4D42-A751-C4F219A2D78FQ47273844-FAD6282C-7A98-4F77-90A6-F206A811FECBQ49667627-B488A2F1-B5D8-4F82-911D-8D0A80CFF639Q49996935-904544B6-FE09-493B-8EA5-FEF9C020D2D4Q51064892-46B3F220-7E3F-4B84-AA90-618B0697FB44
P2860
The effect of pre-analytical variability on the measurement of MRM-MS-based mid- to high-abundance plasma protein biomarkers and a panel of cytokines
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
The effect of pre-analytical v ...... rkers and a panel of cytokines
@ast
The effect of pre-analytical v ...... rkers and a panel of cytokines
@en
The effect of pre-analytical v ...... rkers and a panel of cytokines
@nl
type
label
The effect of pre-analytical v ...... rkers and a panel of cytokines
@ast
The effect of pre-analytical v ...... rkers and a panel of cytokines
@en
The effect of pre-analytical v ...... rkers and a panel of cytokines
@nl
prefLabel
The effect of pre-analytical v ...... rkers and a panel of cytokines
@ast
The effect of pre-analytical v ...... rkers and a panel of cytokines
@en
The effect of pre-analytical v ...... rkers and a panel of cytokines
@nl
P2093
P2860
P3181
P1433
P1476
The effect of pre-analytical v ...... rkers and a panel of cytokines
@en
P2093
Adriana Aguilar-Mahecha
Christoph H Borchers
Dominik Domanski
Mark Basik
Michael A Kuzyk
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0038290
P407
P577
2012-01-01T00:00:00Z